Evidence map›Paper›PMID 37173792›Full record

ArticleAddiction science & clinical practice2023

Integrated smoking cessation and mood management following acute coronary syndrome: Protocol for the post-acute cardiac event smoking (PACES) trial.

Melissa Adkins-Hempel, Sandra J Japuntich, Michelle Chrastek, Shira Dunsiger, Christopher E Breault, Woubeshet Ayenew, Susan A Everson-Rose, Prabhjot S Nijjar, Beth C Bock, Wen-Chih Wu and 3 more

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in Addiction science & clinical practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03413423 (Secondary Prevention Following Acute Coronary Syndrome Using Integrated Smoking Cessation and Mood Management), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03413423 naactive not recruitingnot on this map

Secondary Prevention Following Acute Coronary Syndrome Using Integrated Smoking Cessation and Mood Management

TypeinterventionalSponsorHennepin Healthcare Research InstituteRan2018 to 2026Enrolled233ConditionsAcute Coronary Syndrome, Tobacco UseArmsBAT-CS, Smoking Cessation and Health & Wellness
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Development of the first Iranian clinical practice guidelines for the diagnosis, treatment, and secondary prevention of acute coronary syndrome.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Melissa Adkins-HempelBehavioral Health Equity Research Group, Hennepin Healthcare Research Institute, 701 Park Ave. S9.104, Minneapolis, MN, 55415, USA.
Sandra J JapuntichBehavioral Health Equity Research Group, Hennepin Healthcare Research Institute, 701 Park Ave. S9.104, Minneapolis, MN, 55415, USA.
Michelle ChrastekBehavioral Health Equity Research Group, Hennepin Healthcare Research Institute, 701 Park Ave. S9.104, Minneapolis, MN, 55415, USA.
Shira DunsigerDepartment of Behavioral and Social Sciences, Center for Health Promotion and Health Equity, School of Public Health, Brown University, 121 South Main St., Providence, RI, 02903, USA.
Christopher E BreaultCenter for Behavioral and Preventative Medicine, Lifespan, 1 Hoppin St., Suite 309, Providence, RI, 02903, USA.
Woubeshet AyenewDivision of Cardiology, Department of Medicine, Hennepin Healthcare, 900 South 8th St., O5, Minneapolis, MN, 55415, USA.
Susan A Everson-RoseDivision of General Internal Medicine, Department of Medicine, University of Minnesota, 401 East River Parkway, Suite 131, Minneapolis, MN, 55455, USA.
Prabhjot S NijjarCardiovascular Division, Department of Medicine, University of Minnesota Medical School, 420 Delaware Street SE, MMC 508, Minneapolis, MN, 55455, USA.
Beth C BockCenter for Behavioral and Preventative Medicine, Lifespan, 1 Hoppin St., Suite 309, Providence, RI, 02903, USA.
Wen-Chih WuDepartment of Epidemiology, School of Public Health, Brown University, 121 South Main St., Providence, RI, 02903, USA.
Michael D MiedemaMinneapolis Heart Institute and Minneapolis Heart Institute Foundation, 920 East 28th St., Suite 480, Minneapolis, MN, 55407, USA.
Brett M CarlsonNorth Memorial Health Heart and Vascular Center, 3300 Oakdale Ave. N., Suite 200, Robbinsdale, MN, 55422, USA.
Andrew M BuschBehavioral Health Equity Research Group, Hennepin Healthcare Research Institute, 701 Park Ave. S9.104, Minneapolis, MN, 55415, USA. Andrew.Busch@hcmed.org.ORCID 0000-0002-3577-5960
Brown University · USUniversity of Minnesota · USHennepin Healthcare Research Institute · USUniversity of Minnesota Medical Center · USLifespan · USMinneapolis Heart Institute Foundation · USNorth Memorial Health Care · US

Funding

Secondary Prevention Following Acute Coronary Syndrome Using Integrated Smoking Cessation and Mood ManagementR01HL136327 · NHLBI · HENNEPIN HEALTHCARE RESEARCH INSTITUTE · PI BUSCH, ANDREW M · 2017 to 2022
$2.9M
NHLBI NIH HHS R01 HL136327
6 · The paper itself

Abstract

backgroundApproximately 400,000 people who smoke cigarettes survive Acute Coronary Syndrome (ACS; unstable angina, ST and non-ST elevation myocardial infarction) each year in the US. Continued smoking following ACS is an independent predictor of mortality. Depressed mood post-ACS is also predictive of mortality, and smokers with depressed mood are less likely to abstain from smoking following an ACS. A single, integrated treatment targeting depressed mood and smoking could be effective in reducing post-ACS mortality. METHOD/

designThe overall aim of the current study is to conduct a fully powered efficacy trial enrolling 324 smokers with ACS and randomizing them to 12 weeks of an integrated smoking cessation and mood management treatment [Behavioral Activation Treatment for Cardiac Smokers (BAT-CS)] or control (smoking cessation and general health education). Both groups will be offered 8 weeks of the nicotine patch if medically cleared. Counseling in both arms will be provided by tobacco treatment specialists. Follow-up assessments will be conducted at end-of-treatment (12-weeks) and 6, 9, and 12 months after hospital discharge. We will track major adverse cardiac events and all-cause mortality for 36 months post-discharge. Primary outcomes are depressed mood and biochemically validated 7-day point prevalence abstinence from smoking over 12 months. DISCUSSION: Results of this study will inform smoking cessation treatments post-ACS and provide unique data on the impact of depressed mood on success of post-ACS health behavior change attempts.

trial registrationClinicalTrials.gov, NCT03413423. Registered 29 January 2018. https://beta. CLINICALTRIALS: gov/study/NCT03413423 .

Indexed as

Acute Coronary SyndromeSmoking CessationAftercareHumansPatient DischargeRandomized Controlled Trials as TopicSmokingAcute coronary syndromeBehavioral activationCardiovascular diseaseDepressionSecondary preventionSmoking

Identifiers

PMID37173792
PMCPMC10175930
OpenAlexW4376255349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.